INSTRUCTIONS TO AUTHORS
International Journal of Therapies and Rehabilitation Research (IJTRR) accepts manuscripts in specialty areas of Rehabilitation Medicine, Physiotherapy, Occupational therapy, Yoga Therapy, Audiology and Speech Therapy, Podiatry, Rehabilitation Nursing, Psychology, Medico-Social Work, Vocational Rehabilitation, Special Education, and Alternative Medicine. IJTRR operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Decision on manuscript is communicated to authors within six to eight weeks.
Manuscript should be written in English.
The manuscript should be formatted double spaced in 10-point Arial font, with pages and lines numbered.
Manuscripts should be written in accordance with recommendations from “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” by the International Committee of Medical Journal Editors, April 2010 (http://www.icmje.org/urm_full.pdf)
Manuscript should be submitted as one file with tables and figures in MS word, along with copy right form and conflict of interest form by online submission or electronically to email@example.com
Ethical Approval and Informed Consent. For all manuscripts reporting data from studies involving human participants, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section.
Manuscripts should be organized in the following order
- Title page
- Abstract; should be clear, descriptive, self-explanatory and not longer than 250 words.
- Body of text (divided by subheadings: Introduction, Material and Methods, Results, Discussion, and Conclusion)
- Conflict of interest
The title should appear on a separate page which should then followed by the author name and the institution name and address by indicating suitable superscripts. Title page should contain title of the paper in bold face, title case (font size 14), names of the authors in normal face, upper case (font size 12) followed by the address(es) in normal face lower case. An asterisk (*) must be placed after the corresponding authors name as superscript whose email id, fax, telephone number can be given at the bottom left corner of the title. Corresponding author has the responsibility to ensure that all co-authors are aware and approve the contents of the submitted manuscript.
This section should start on a new page and should detail the problems, experimental approach, major findings and conclusion in one paragraph and should appear on the second page. Avoid abbreviation, diagram and references in the abstract. It should be single – spaced and should not exceed 150 words for full papers.
Author(s) must give about 4-6 key words which can identify the most important subjects covered by the paper. They must be placed at the end of the abstract.
The manuscript should include a brief introduction stating the purpose of the investigation and relating the manuscript to similar previous research. Only information essential to the arguments should be presented.
Materials and Methods
The methods section should describe, in logical sequence, how the study was designed (e.g. how randomization was done), carried out (e.g. how subjects were chosen or excluded, ethical considerations, accurate details of materials used, exact treatment dosage and form of treatment) and data were analyzed (e.g. an estimate of the power of the study, exact test used for statistical analysis). For standard methods, appropriate references are sufficient, but if standard methods are modified these should be clearly brought out. Authors should provide complete details of any new methods or apparatus used.
Tables should be used wherever necessary and should have rows and columns to correlate the variables. It should be cell- based type (Microsoft word tables). Do not use tabs or hard returns during preparation of tables. Do not send us tables as graphics. Tables should be as compact as possible. Unnecessary rows and columns can be avoided. The table should be double spaced and separated from the text. The font can be of same size used in the text of the manuscript. Do not divide the table in to sub tables and not to use vertical or horizontal rules/lines. Table should be numbered accordingly in numeric order. The table should be numbered in roman numeral followed by the title. The title should be one-line title in bold text with font size 12. Abbreviations can be used if needed and abbreviations that are used only in a table should be defined in the footnotes to that table and should be designated with superscript/subscript letters. Avoid “Ditto” marks. The units used should be in SI nomenclature or the nomenclature common to a particular field. Unusual units or abbreviations can be defined in the legend
Figures should be used wherever necessary. The figures can be of GIF/TIFF/JPEG/PDF. The figures should be comprehensible for the readers and should help them in understanding the paper. Unnecessary figures should be avoided. Avoid unnecessary colouring and excessive details. The title should be one-line title in bold text with font size 12. Abbreviations can be used if needed and abbreviations that are used only in the figures should be defined in the footnotes to that figure. The title should describe the contents so each illustration can be understood on considering apart from the text. All figures should be numbered in roman numerals and should be cited in the text accordingly. The image/photograph should be cropped to show essential details. Magnification can be indicated by inserting the scale bar. The image/photograph should be clear and of high quality. Poor blurred or out of focus letters/symbols are not acceptable. The units used should be SI nomenclature or the nomenclature common to a particular field. Unusual units or abbreviations can be defined in the legend.
Results and Discussion
The results should be concisely presented. Results and discussion may be separate or combined based on the authors requirement.
Manuscript should have relevant brief conclusion (limit of 300) and should reflect the importance and future scope.
This section can be kept at the end of the manuscript before reference section and should not be more than 50 words. This section can be used to acknowledge the help of those who do not qualify for authorship or to acknowledge funding, donated resources or significant contribution to the research
Conflict of Interest
Manuscript should have the declaration of conflict of interest. Conflict of Interest form should be submitted along with the manuscript.
Click here to download conflict of interest form
Copy Right form
All authors should sign the form. If any author is not available, the corresponding authored can sign the form prefixing “for” after getting permission author.
This copy right form should be along with manuscript
Click here to download copy right form
Original research: 3000 words of text (not including abstract, tables, figures, references) with no more than a total of 5 tables and/or figures
Systematic review/ Review/Meta-analysis: 3500 words of text (not including abstract, tables, figures, references, and online-only material), with no more than a total of 4 tables and/or figures and no more than 50-75 references.
Short communication: 1000-1500 words (not including abstract, tables, figures, references, and online-only material) with no more than a total of 3 tables and/or figures.
Case report: 1500 words Editorial: 1000 words.
Authors are requested to suggest two potential reviewers for the manuscript and provide their contact address and e-mail addresses. Potential reviewers should be experts, and should have published in the area of research. Authors should not suggest reviewers from the same institutions or individuals whom they have collaborated or published with in the past.
PROOFS AND REPRINTS
Electronic proofs will be sent (e-mail attachment) to the corresponding author as a MS word file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. The manuscript will be published within two weeks after receiving proof read. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
Details of Reporting Guidelines for Different Study Designs
Research and Publication Ethics
For the policies on the research and publication ethics not stated in this instruction, please refer to Guidelines on Good Publication (http://publicationethics.org/)
Conflict of interest exists when an author (or the author’s institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from being negligible to having great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion (http://icmje.org/ethical_4conflicts.html). If there are any conflicts of interest, authors should disclose them in the manuscript. The conflicts of interest may occur during research process; however, important point is the disclosure itself. If there is a disclosure, editors, reviewers, and reader can approach the manuscripts after understanding the situation where the research work was processed.
Statement of Human and Animal Right
Clinical research should be done in accordance of the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Helsinki Declaration of 1975 (revised 2008), available from: http://www.wma.net/en/30publications/10policies/b3/. Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.
Statement of Informed Consent and Institutional Review Board Approval
Copies of written informed consents should be kept for studies on human subjects. For the clinical studies of human subjects, there should be a certificate, agreement by the Institutional Review Board (IRB) of author's institute. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.
Registration of the Clinical Trial Research
Any researches that deals with clinical trial should be registered to the primary national clinical trial registration site such as national registry sites accredited by World Health Organization (http://www.who.int/ictrp/network/primary/en/) or clinicaltrial.gov (http://clinicaltrial.gov/), a service of the Unite States National Institutes of Health.
Authorship/ Authors responsibilities
Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published (http://icmje.org/ethical_1author.html). Authors should meet these 3 conditions. If the number of authors is greater than 6, there should be a list of each author's role for the submitted paper. If any persons who do not meet above three criteria, they may be placed as contributors in Acknowledgments section. Description of co-first authors or co-corresponding authors is also accepted if corresponding author believes that their roles are equally contributed.
Originality and Duplicate Publication
All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board, although the figures and tables can be used freely if original source is verified according to Creative Commons License. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal that is not open access.
It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by International Committee of Medical Journal Editors', available from: http://www.icmje.org/publishing_4overlap.html as followings:
Certain types of articles, such as guidelines produced by governmental agencies and professional organizations, may need to reach the widest possible audience. In such instances, editors sometimes deliberately publish material that is also being published in other journals, with the agreement of the authors and the editors of those journals. Secondary publication for various other reasons, in the same or another language, especially in other countries, is justifiable and can be beneficial provided that the following conditions are met.
The authors have received approval from the editors of both journals (the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version).
The priority of the primary publication is respected by a publication interval of at least 1 week (unless specifically negotiated otherwise by both editors).
The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
The secondary version faithfully reflects the data and interpretations of the primary version.
The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].” Permission for such secondary publication should be free of charge.
The title of the secondary publication should indicate that it is a secondary publication (complete republication, abridged republication, complete translation, or abridged translation) of a primary publication. Of note, the United States National Library of Medicine (NLM) does not consider translations to be “republications” and does not cite or index translations when the original article was published in a journal that is indexed in Medline.
Editors of journals that simultaneously publish in multiple languages should understand that NLM indexes the primary language version. When the full text of an article appears in more than one language in a journal issue (such as Canadian journals with the article in both English and French), both languages are indicated in the Medline citation (for example, Mercer K. The relentless challenge in health care. Healthc Manage Forum. 2008 Summer;21(2):4-5. English, French. No abstract available. PMID:18795553.)
Process to Manage the Research and Publication Misconduct
When the Journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflict of interest, ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc, The resolving process will be followed by flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are done by Editorial Board.
All of a journal’s content should be subjected to peer-review process. Authors are welcome to submit two potential reviewers who are expert in the field, however; the Editor chooses the experts.
Stages of review process
- The corresponding author submit manuscript to the IJTRR via email at firstname.lastname@example.org or via Scopemed editorial management system at http://my.ejmanager.com/ijtrr/
- The Journal editor assess the manuscript for suitability and send manuscript to the reviewers for review or may reject the manuscript at this stage if manuscript is not within the IJTRR scope or not novel.
- The IJTRR operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Decision on manuscript is communicated to authors within six to eight weeks.
- Editor review the reviewer’s comments and may send the comments to the corresponding author for revision.
- Editor review the authors revision and may accept or reject the manuscript.
Copy Right and Access
IJTRR is an open and online journal and freely available at http://onlineijtrr.com. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
All the published articles are given DOI number and are archived automatically at Scopemed online journal management system at www.onlineijtrr.com
Article processing fee: INR 2000 (two thousand only) for Indian nationals and US$ 50 for foreign nationals will be charged upon acceptance of manuscript.